Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis

European Journal of Neurology

Volumn 14, Issue 4, 2007, Pages 379-386

  Park, J H ^a,b   Kwon, H M ^b,c   Roh, J K ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Intimal medial thickness; Intracranial atherosclerosis; Magnetic resonance angiography; Metabolic syndrome; Stroke subtype

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HUMAN; HYPERGLYCEMIA; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METABOLIC SYNDROME X;

EID: 33947592350     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01682.x     Document Type: Article

References (37)

1. Kinney JM Insulin resistance in the elderly - the focus enlarges. Current Opinion in Clinical Nutrition and Metabolic Care 2002; 5: 11-17.
2. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistance and risk for stroke. Neurology 2002; 59: 809-815.
3. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104: 2815-2819.
4. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). American Journal of Cardiology 2002; 90: 953-958.
5. Raitakari OT, Juonala M, Kahonen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. Journal of the American Medical Association 2003; 290: 2277-2283.
6. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. Lancet 2005; 366: 1059-1062.
7. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
8. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735-2752.
9. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.
10. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790-1794.
11. Adams HP , Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in multicenter clinical trial. TOAST. Stroke 1993; 24: 35-41.
12. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. Journal of the American Medical Association 2001; 285: 2486-2497.
13. Western Pacific Regional Office of the World Health Organization. The international Obesity Task Force: The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia, 2000.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499-502.
15. Uehara T, Mori E, Tabuchi M, Ohsumi Y, Yamadori A. Detection of occlusive lesions in intracranial arteries by three-dimensional time-of-flight magnetic resonance angiography. Cerebrovascular Diseases 1994; 4: 365-370.
16. Uehara T, Tabuchi M, Ohsumi Y, Yoneda Y, Mori E. Usefulness of three-dimensional time-of-flight MR angiography for evaluation of carotid artery bifurcation stenosis. Cerebrovascular Diseases 1995; 5: 199-203.
17. North American Symptomaic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. New England Journal of Medicine 1991; 325: 445-453.
18. Bang OY, Kim JW, Lee JH et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65: 296-298.
19. Seshadri S, Wolf PA, Beiser A et al. Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study. Archives of Internal Medicine 2001; 161: 2343-2350.
20. Sowers JR. Insulin resistance, hyperinsulinemia, dyslipidemia, hypertension, and accelerated atherosclerosis. Journal of Clinical Pharmacology 1992; 32: 529-535.
21. Arcaro G, Cretti A, Balzano S et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576-82.
22. Howard BV. Insulin resistance and lipid metabolism. American Journal of Cardiology 1999; 84: 28-32.
23. Tripathy D, Mohanty P, Dhindsa S et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003; 52: 2882-2887.
24. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome. A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454.
25. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apo B-lipoprotein-depleted plasma [FER (HDL)]. Clinical Biochemistry 2001; 34: 583-588.
26. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005; 36: 1372-1376.
27. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52: 2346-2352.
28. D'Armiento FP, Bianchi A, de Nigris F et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001; 32: 2472-2480.
29. Whincup PH, Gilg JA, Donald AE et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 2005; 112: 1789-1797.
30. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 1432-1443.
31. Giltay EJ, Lambert J, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women. Diabetologia 1999; 42: 214-221.
32. Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke 1999; 30: 1319-1325.
33. Schumacher HC, Tanji K, Mangla S et al. Histopathological evaluation of middle cerebral artery after percutaneous intracranial transluminal angioplasty. Stroke 2003; 34: 170-173.
34. Shahar E, Chambless LE, Rosamond WD et al. Atherosclerosis Risk in Communities Study. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2003; 34: 623-631.
35. Giulio M, Anna DB, Roberto M, Giovanni DM. Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update. Arteriosclerosis, Thrombosis, and Vascular Biology 1999; 19: 1368-1377.
36. Nieuwdorp M, Stroes ES, Meijers JC, Buller H. Hypercoagulability in the metabolic syndrome. Current Opinion in Pharmacology 2005; 5: 155-159.
37. Feldmann E, Dauneault N, Kwan E et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541-1545.